9RU-23130-55563
4 vaccinations
4 coded responses
29 check-ins
4 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 51-55
- ZIP prefix
- 117 / NY
- Registered
- 2021-02-27
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-26
Dose 1 — Pfizer-BioNTech
-
2021-02-27
Registered in v-safe
- 2021-02-28
- 2021-03-01
- 2021-03-02
- 2021-03-03
- 2021-03-05
- 2021-03-12
-
2021-03-19
Dose 2 — Pfizer-BioNTech
- 2021-03-19
-
2021-03-20
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2021-03-21
Survey response — days 1–6 daily, dose 2MedDRA: Burn oesophageal, Decreased appetite, Dyspnoea, Dyspnoea exertional, Lower respiratory tract infection — Feeling: Fair · Site: Pain · Fatigue or tirednessFree text: No appetite Friday or Saturday. I went running Sunday morning and my esophagus burned as if I had a chest cold, breathing a little labored. Same when I continued floor exercises at home.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-22
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Headache, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
- 2021-03-23
- 2021-03-24
-
2021-03-25
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-03-26
- 2021-04-02
- 2021-04-11
- 2021-04-16
- 2021-04-23
-
2021-05-01
Survey response — day 42, dose 2MedDRA: Dyspnoea, Headache — Feeling: GoodFree text: Frequent headaches. Get winded more easily during exercise.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-06-18
- 2021-09-17
-
2021-12-03
Dose 3 — Moderna
-
2022-03-21
Survey response — 12 months, dose 2MedDRA: Ageusia, Anosmia, COVID-19 — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Diagnosed with COVID early January 2022 after 2x Pfizer vax Feb-Mar 2021 and Moderna booster in Dec 2021. Loss of taste and smell after contracting COVIDMedDRA releases: 2024-11 · check-in free text available
-
2022-04-06
Dose 4 — Other-UnknownCo-administered: Shingles
-
2022-04-23
Survey response — day 14, dose 4MedDRA: Ageusia, Anosmia, COVID-19 — Feeling: GoodFree text: Had COVID inJanuary 2022 and lost sensbof smell and taste. It is still not back entirely.MedDRA releases: 2024-11 · check-in free text available
- 2022-04-29
- 2022-05-11
- 2022-05-19
- 2022-07-08
- 2022-10-07
- 2023-04-08
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-26 | Pfizer-BioNTech | |
| 2 | 2021-03-19 | Pfizer-BioNTech | |
| 3 | 2021-12-03 | Moderna | No |
| 4 | 2022-04-06 | Other-Unknown | Shingles |
Free text
Release 6 — days 1–6 daily, dose 2
Systemic reaction (other): No appetite Friday or Saturday. I went running Sunday morning and my esophagus burned as if I had a chest cold, breathing a little labored. Same when I continued floor exercises at home.
Release 8 — day 42, dose 2
Symptoms: Frequent headaches. Get winded more easily during exercise.
Release 11 — 12 months, dose 2
Symptoms: Diagnosed with COVID early January 2022 after 2x Pfizer vax Feb-Mar 2021 and Moderna booster in Dec 2021. Loss of taste and smell after contracting COVID
Release 11 — day 14, dose 4
Symptoms: Had COVID inJanuary 2022 and lost sensbof smell and taste. It is still not back entirely.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Ageusia | · | · | ✓ |
| SD | Anosmia | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Dyspnoea | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SRO | Burn oesophageal | ✓ | ✓ | ✓ |
| SRO | Decreased appetite | ✓ | ✓ | ✓ |
| SRO | Dyspnoea | ✓ | ✓ | ✓ |
| SRO | Dyspnoea exertional | ✓ | ✓ | ✓ |
| SRO | Lower respiratory tract infection | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release